Skip to main content

Genetesis adds 3 to executive team as FDA 'de novo' approval looms

Genetesis has added three new executives to its team as it nears a key FDA approval.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.